Singapore: New fee structure aims to foster innovation

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Singapore: New fee structure aims to foster innovation

The Intellectual Property Office of Singapore (IPOS) announced a fee revision for patents and trade marks with effect from April 1 2017. Regarding patents, the application fees for searches or supplementary search reports, local search and examination reports, and international search and examination reports, are reduced by 14%, 25% and 37%, respectively. There is also a 30% fee reduction in the application to register trade marks that utilise the IPOS pre-approved list of goods and services. Thus, businesses and entrepreneurs will see a substantial fee reduction for patent and trade mark applications.

In addition, a new excess claim fee structure is introduced that is payable when requesting combined search and examination (S&E), examination (E) and grant. Previously, excess claim fees were only payable at time of grant. With the revised fees, $40 is charged per claim in excess of 20 claims when requesting S&E or E and is payable together with a grant fee for claims in excess of the number of claims previously paid (i.e. only the excess unpaid claims will be charged on grant). The changes to the claim fee structure will streamline the patent application process at IPOS and encourage applicants to file claims sets that are concise with the aim of saving costs and time required for the patent application process.

The fee revision also includes an increase in patent renewal fees from the eighth year onwards and an increase in trade mark renewal fees. While this renewal fee revision increases the overall lifecycle costs for patents and trade marks in Singapore, Singapore continues to remain competitive with lower overall lifecycle costs as compared to other countries such as Korea, Japan, China, the USA and Australia.

According to IPOS, the increase in renewal fees will discourage IP hoarding by encouraging IP owners to utilise their valuable IP while releasing non-performing IP to the public domain. To further facilitate this initiative, the fees for surrendering or cancelling IP are removed. Additionally, applicants who license their patents will enjoy a 50% discount off their renewal fees. Thus businesses are encouraged to manage their IP portfolio strategically.

Collopy_Dan

Shahera Anwar

Daniel Collopy


Spruson & Ferguson (Asia) Pte Ltd152 Beach Road#37-05/06 Gateway EastSingapore 189721Tel: +65 6333 7200Fax: +65 6333 7222mail.asia@spruson.comwww.spruson.com

more from across site and SHARED ros bottom lb

More from across our site

VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Matteo Di Lernia, advocate at LCA Studio Legale, unpicks the CJEU’s ruling in M.M. Ristorazione v Villa Ramazzini, including its impact on litigation strategies
Gift this article